FDA Inspection 1305472 — Takeda GmbH
The FDA completed an inspection of Takeda GmbH on Nov 12, 2025 in Singen (Hohentwiel). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singen (Hohentwiel) (Germany)
Additional details
Mutual Recognition Agreement (MRA)